Cases reports: Unintended anti‐doping rule violation after dorzolamide use several months prior to a doping control.
- Published in:
- Drug Testing & Analysis, 2021, v. 13, n. 10, p. 1803, doi. 10.1002/dta.3156
- By:
- Publication type:
- Article
Works matching IS 1942-7603 AND VI 13 AND IP 10 AND DT 2021
Results: 15
1
2
Stability study of the antiviral agent camphecene in dried blood spots at different temperatures.
- Published in:
- Drug Testing & Analysis, 2021, v. 13, n. 10, p. 1797, doi. 10.1002/dta.3148
- By:
- Publication type:
- Article
3
Multiplexed detection of agents affecting erythropoiesis (AAEs) and overall strategy for optimizing initial testing procedure.
- Published in:
- Drug Testing & Analysis, 2021, v. 13, n. 10, p. 1791, doi. 10.1002/dta.3136
- By:
- Publication type:
- Article
4
No pain, just gain: Painless, easy, and fast dried blood spot collection from fingertip and upper arm in doping control.
- Published in:
- Drug Testing & Analysis, 2021, v. 13, n. 10, p. 1783, doi. 10.1002/dta.3135
- By:
- Publication type:
- Article
5
Blood‐to‐muscle distribution and urinary excretion of higenamine in rats.
- Published in:
- Drug Testing & Analysis, 2021, v. 13, n. 10, p. 1776, doi. 10.1002/dta.3132
- By:
- Publication type:
- Article
6
Robustness of digital PCR and real‐time PCR against inhibitors in transgene detection for gene doping control in equestrian sports.
- Published in:
- Drug Testing & Analysis, 2021, v. 13, n. 10, p. 1768, doi. 10.1002/dta.3131
- By:
- Publication type:
- Article
7
Synthetic cannabinoid receptor agonists and their human metabolites in sewage water: Stability assessment and identification of transformation products.
- Published in:
- Drug Testing & Analysis, 2021, v. 13, n. 10, p. 1758, doi. 10.1002/dta.3129
- By:
- Publication type:
- Article
8
The in vivo metabolism of Furazadrol in greyhounds.
- Published in:
- Drug Testing & Analysis, 2021, v. 13, n. 10, p. 1749, doi. 10.1002/dta.3128
- By:
- Publication type:
- Article
9
Hydromorphone and codeine concentrations in oral fluid specimens from patients receiving substitution therapy with Substitol™ (morphine sulfate).
- Published in:
- Drug Testing & Analysis, 2021, v. 13, n. 10, p. 1743, doi. 10.1002/dta.3127
- By:
- Publication type:
- Article
10
False negative results in testosterone doping in forensic cases: Sensitivity of the urinary detection criteria T/E and T/LH.
- Published in:
- Drug Testing & Analysis, 2021, v. 13, n. 10, p. 1735, doi. 10.1002/dta.3125
- By:
- Publication type:
- Article
11
Pharmacokinetic profiles of a SARS‐COV‐2 neutralizing antibody BD‐604 in cynomolgus monkeys.
- Published in:
- Drug Testing & Analysis, 2021, v. 13, n. 10, p. 1727, doi. 10.1002/dta.3122
- By:
- Publication type:
- Article
12
Effects of the administration of miconazole by different routes on the biomarkers of the "steroidal module" of the Athlete Biological Passport.
- Published in:
- Drug Testing & Analysis, 2021, v. 13, n. 10, p. 1712, doi. 10.1002/dta.3121
- By:
- Publication type:
- Article
13
Metonitazene in the United States—Forensic toxicology assessment of a potent new synthetic opioid using liquid chromatography mass spectrometry.
- Published in:
- Drug Testing & Analysis, 2021, v. 13, n. 10, p. 1697, doi. 10.1002/dta.3115
- By:
- Publication type:
- Article
14
Cover Picture.
- Published in:
- Drug Testing & Analysis, 2021, v. 13, n. 10, p. i, doi. 10.1002/dta.2854
- Publication type:
- Article
15
Issue Information.
- Published in:
- Drug Testing & Analysis, 2021, v. 13, n. 10, p. 1693, doi. 10.1002/dta.2853
- Publication type:
- Article